Particularly, they directly or indirectly suppress CD8+ tumor-infiltrating lymphocytes, release immunosuppressive factors such as IL-10, and enhance tumor cell growth and extravasation by fostering vascularization and extracellular matrix (ECM) remodeling [7]. The gene discussed is CD8A; the disease is neoplasm.